Beijing Leadman Biochemistry Co Ltd
SZSE:300289
Wall Street
Price Targets
Price Targets Summary
Beijing Leadman Biochemistry Co Ltd
According to Wall Street analysts, the average 1-year price target for Beijing Leadman Biochemistry Co Ltd is 17 CNY .
Operating Income
Forecast
Operating Income Estimate
Beijing Leadman Biochemistry Co Ltd
For the last 8 years the compound annual growth rate for Beijing Leadman Biochemistry Co Ltd's operating income is -24%. The projected CAGR for the next 8 years is 31%.
Net Income
Forecast
Net Income Estimate
Beijing Leadman Biochemistry Co Ltd
For the last 8 years the compound annual growth rate for Beijing Leadman Biochemistry Co Ltd's net income is -25%. The projected CAGR for the next 8 years is 38%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Beijing Leadman Biochemistry Co Ltd's stock price target?
Price Target
17
CNY
According to Wall Street analysts, the average 1-year price target for Beijing Leadman Biochemistry Co Ltd is 17 CNY .
What is Beijing Leadman Biochemistry Co Ltd's Revenue forecast?
Projected CAGR
5%
For the last 8 years the compound annual growth rate for Beijing Leadman Biochemistry Co Ltd's revenue is -5%. The projected CAGR for the next 8 years is 5%.
What is Beijing Leadman Biochemistry Co Ltd's Operating Income forecast?
Projected CAGR
31%
For the last 8 years the compound annual growth rate for Beijing Leadman Biochemistry Co Ltd's operating income is -24%. The projected CAGR for the next 8 years is 31%.
What is Beijing Leadman Biochemistry Co Ltd's Net Income forecast?
Projected CAGR
38%
For the last 8 years the compound annual growth rate for Beijing Leadman Biochemistry Co Ltd's net income is -25%. The projected CAGR for the next 8 years is 38%.